Macquarie Group Ltd. lessened its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 20.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 125,703 shares of the medical technology company’s stock after selling 32,208 shares during the period. Macquarie Group Ltd. owned 0.28% of Teleflex worth $31,278,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also modified their holdings of the company. Aristotle Atlantic Partners LLC acquired a new stake in shares of Teleflex during the 4th quarter worth about $202,000. Coldstream Capital Management Inc. acquired a new stake in shares of Teleflex during the 3rd quarter worth about $226,000. Quantitative Systematic Strategies LLC acquired a new stake in shares of Teleflex during the 4th quarter worth about $228,000. Checchi Capital Advisers LLC acquired a new stake in shares of Teleflex during the 4th quarter worth about $230,000. Finally, Lourd Capital LLC acquired a new stake in shares of Teleflex during the 4th quarter worth about $266,000. 90.75% of the stock is currently owned by institutional investors and hedge funds.
In other Teleflex news, Director George Babich, Jr. sold 2,500 shares of Teleflex stock in a transaction that occurred on Monday, March 12th. The stock was sold at an average price of $268.53, for a total transaction of $671,325.00. Following the transaction, the director now owns 11,083 shares of the company’s stock, valued at $2,976,117.99. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Stephen K. M.D. Klasko sold 200 shares of Teleflex stock in a transaction that occurred on Tuesday, January 2nd. The stock was sold at an average price of $248.96, for a total value of $49,792.00. Following the transaction, the director now directly owns 8,080 shares in the company, valued at approximately $2,011,596.80. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 14,259 shares of company stock worth $3,760,536. 2.39% of the stock is currently owned by corporate insiders.
Teleflex stock opened at $260.05 on Thursday. The company has a market capitalization of $11,950.67, a P/E ratio of 31.58, a price-to-earnings-growth ratio of 1.96 and a beta of 1.22. Teleflex Incorporated has a 12-month low of $191.04 and a 12-month high of $288.78. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.51 and a current ratio of 2.33.
Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, February 22nd. The medical technology company reported $2.44 EPS for the quarter, topping the consensus estimate of $2.40 by $0.04. The company had revenue of $595.10 million for the quarter, compared to analyst estimates of $601.17 million. Teleflex had a return on equity of 16.46% and a net margin of 7.11%. The firm’s revenue was up 15.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.13 earnings per share. equities analysts expect that Teleflex Incorporated will post 9.66 EPS for the current year.
The company also recently declared a quarterly dividend, which was paid on Thursday, March 15th. Shareholders of record on Friday, March 2nd were given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.52%. The ex-dividend date was Thursday, March 1st. Teleflex’s dividend payout ratio (DPR) is 41.59%.
TRADEMARK VIOLATION NOTICE: “Teleflex Incorporated (TFX) Shares Sold by Macquarie Group Ltd.” was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be accessed at https://www.tickerreport.com/banking-finance/3289366/teleflex-incorporated-tfx-shares-sold-by-macquarie-group-ltd.html.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.